Given the possible effects of androgens on pancreatic cancer, several prospective randomized controlled trials have explored the effects of androgen receptor inhibitors on pancreatic cancer; however, the findings have been inconsistent y[43, 44]. This evidence concerns the gene AR and pancreatic neoplasm.